Developments in the treatment of nail psoriasis, melanonychia striata, and onychomycosis: A review of the literature

Dermatologic Clinics

Volumn 18, Issue 1, 2000, Pages 37-46

  Van Laborde, Stephen ^b   Scher, Richard K ^b  

^a Presbyterian Medical Center ^*  (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; ANTIFUNGAL AGENT; BENZODIAZEPINE; BENZYLAMINE DERIVATIVE; BETAMETHASONE DIPROPIONATE; BUTENAFINE; CALCIPOTRIOL; CISAPRIDE; CLOBETASONE; CORTICOSTEROID; DITHRANOL; FLUCONAZOLE; FLUOROURACIL; HISTAMINE H2 RECEPTOR ANTAGONIST; ITRACONAZOLE; MEVINOLIN; MIDAZOLAM; ORAL ANTIDIABETIC AGENT; ORAL CONTRACEPTIVE AGENT; RETINOID; SALICYLIC ACID; SILICIC ACID; SIMVASTATIN; SULFONYLUREA DERIVATIVE; TAZAROTENE; TERBINAFINE; TRIAMCINOLONE ACETONIDE; TRIAZOLAM; UNINDEXED DRUG; VITAMIN D DERIVATIVE;

DRUG INDUCED DISEASE; ERYTHEMA; GASTROINTESTINAL TOXICITY; HEADACHE; HUMAN; HYPERKERATOSIS; NAIL DISEASE; ONYCHOMYCOSIS; PRIORITY JOURNAL; PSORIASIS; REVIEW;

EID: 0033961691     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0733-8635(05)70145-5     Document Type: Review

References (56)

1. C.C. Banfield R.P.R. Dawber N.P.J. Walker Mohs micrographic surgery for the treatment of in situ nail apparatus melanoma: A case report J Am Acad Dermatol 40 1999 98 99
2. R. Baran P. Kechijian Hutchinson's sign: A reappraisal J Am Acad Dermatol 34 1996 87 90
3. R. Baran P. Kechijian Longitudinal melanonychia (melanonychia striata): Diagnosis and management J Am Acad Dermatol 21 1989 1165 1175
4. D.D. Bikle Vitamin D: A calciotropic hormone regulating calcium-induced keratinocyte differentiation J Am Acad Dermatol 37 1997 S42 S52
5. J.B. Bikowski Case report: Subungual corticosteroid solution for psoriatic onycholysis Skin & Aging 6 1998 23
6. M. Brautigam Terbinafine versus itraconazole: A controlled clinical comparison in onychomycosis of the toenails J Am Acad Dermatol 38 1998 S53 S56
7. R.A.S. Chandraratna Rational design of receptor-selective retinoids J Am Acad Dermatol 39 1998 S124 S128
8. de Berker D.A.R. C.M. Lawrence A simplified protocol of steroid injection for psoriatic nail dystrophy Br J Dermatol 138 1998 90 95
9. Del Rosso J.Q. P.J. Basuk R.K. Scher Dermatologic diseases of the nail unit Scher R.K. Daniel R. Nails: Therapy, Diagnosis, Surgery ed 2 1997 WB Saunders Philadelphia
10. B.E. Elewski Once-weekly fluconazole in the treatment of onychomycosis: Introduction J Am Acad Dermatol 38 1998 S73 S76
11. B.E. Elewski M.A. Charif R. Daniel Onychomycosis Scher R.K. Daniel R. Nails: Therapy, Diagnosis, Surgery ed 2 1997 WB Saunders Philadelphia
12. E.G. Evans B. Sigurgeirsson Double blind, randomised study of continuous terbinatine compared with intermittent intraconazole in treatment of toenail onychomycosis. The Lion Study Group BMJ 318 1999 1031 1035
13. E.M. Farber L. Nall Nail psoriasis Cutis 50 1992 174 178
14. S.F. Friedlander The evolving role of intraconazole, fluconazole and terbinatine in the treatment of tinea capitis Pediatr Infect Dis J 18 1999 205 210
15. K. Fritz Psoriasis of the nail: Successful topical treatment with 5-fluorouracil Zeitschrift Fur Hautkrankheiten 64 1989 1083 1088
16. P.M. Glat J.A. Spector D.F. Roses The management of pigmented lesions of the nail bed Ann Plast Surg 11 1996 183 189
17. S. Goettmann-Bonvallot J. Andre S. Belaich Longitudinal melanonychia in children: A clinical and histopathologic study of 40 cases J Am Acad Dermatol 41 1999 17 22
18. A.K. Gupta P. Adam S.L.R. Hofstader Itraconazole oral solution for the treatment of onychomycosis Pediatr Dermatol 15 1998 472 474
19. A.K. Gupta P. Chang Del Rosso J.Q. Onychomycosis in children: Prevalence and management Pediatr Dermatol 15 1998 464 471
20. A.K. Gupta C.R. Daniel Factors that may affect the response of onychomycosis to oral antifungal therapy Australas J Dermatol 39 1998 222 224
21. A.K. Gupta C.R. Daniel Onychomycosis: Strategies to reduce failure and recurrence Cutis 62 1998 189 191
22. A.K. Gupta H.C. Jain C.W. Lynde Prevalence and epidemiology of unsuspected onychomycosis in patients visiting dermatologists' offices in Ontario, Canada: A multicenter survey of 2001 patients Int J Dermatol 36 1998 783 787
23. A.K. Gupta D.N. Sauder N.H. Shear Antifungal agents: An overview. Part II J Am Acad Dermatol 30 1994 911 933
24. A.K. Gupta R.K. Scher P. Rich Fluconazole for the treatment of onychomycosis: An update Int J Dermatol 37 1998 815 820
25. A.K. Gupta R.G. Sibbald C.W. Lynde The prevalence of onychomycosis in children and treatment strategies J Am Acad Dermatol 36 1997 395 402
26. E. Haneke D. Abeck J. Ring Safety and efficacy of intermittent therapy with itraconazole in finger- and toenail onychomycosis: A multicentre trial Mycoses 41 1998 521 527
27. R.J. Hay Pharmacokinetic evaluation of fluconazole in skin and nails Int J Dermatol 31 suppl. 2 1992 6 7
28. D.A. Hudson J.E.J. Krige R.M. Strover J Hand Surg [Am] 15B 1995 288 290
29. H.I. Katz Systemic antifungal agents used to treat onychomycosis J Am Acad Dermatol 38 1998 S48 S52
30. J.M. Klausner M. Inbar M. Gutman Nail-bed melanoma J Surg Oncol 34 1987 208 210
31. K. Kragballe The future of vitamin D in dermatology J Am Acad Dermatol 37 1997 S72 S76
32. A. Lassus Colloidal silicic acid for the treatment of psoriatic skin lesions, arthropathy and onychopathy. A pilot study J Int Med Res 25 1997 206 209
33. C. Leaute-Labreze Longitudinal melanonychia in children Arch Dermatol 132 1996 167 169
34. M. Lebwohl Clinical efficacy and safety of tazarotene: Optimizing clinical results Cutis 61 1989 27 29
35. M. Lebwohl M. Duvic Menter Excerpt of panel discussion from symposium Cutis 61 1998 S30 S35
36. M. Lebwohl Y. Poulin Tazarotene in combination with topical corticosteroids J Am Acad Dermatol 39 1998 S139 S143
37. Levit E, Kagen M, Scher RK, et al: The alphabet of subungual melanoma. J Am Acad Dermatol (in press)
38. R. Marks Pharmacokinetics and safety review of tazarotene J Am Acad Dermatol 39 1998 S134 S138
39. L.A. Norton Tumors Scher R.K. Daniel R. Nails: Therapy, Diagnosis, Surgery ed. 2 1997 WB Saunders Philadelphia
40. R.B. Odom New therapies for onychomycosis J Am Acad Dermatol 35 1996 S26 S30
41. A.S. Pappert R.K. Scher J.L. Cohen Longitudinal pigmented nail bands Dermatol Clin 9 1991 703 716
42. C.A. Ramsay Management of psoriasis with calcipotriol used as monotherapy J Am Acad Dermatol 37 1997 S53 S54
43. P. Rich R.K. Scher D. Breneman Pharmacokinetics of three doses of once-weekly fluconazole (150, 300, and 450 mg) in distal subungual onychomycosis of the toenail J Am Acad Dermatol 38 1998 S103 S109
44. P. Sau S.L. McMarlin L.C. Sperling Bowen's disease of the nail bed and periungual area: A clinicopathological analysis of seven cases Arch Dermatol 130 1994 204 209
45. R.K. Scher Psoriasis of the nail Dermatol Clin 3 1985 387 394
46. R.K. Scher D. Breneman P. Rich Once weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail J Am Acad Dermatol 38 1998 S77 S86
47. D.J. Schissel D.M. Elston Topical 5-Fluorouracil treatment for psoriatic trachyonychia Cutis 62 1998 27 28
48. S.M. Suarez D.N. Silvers R.K. Scher Histologic evaluation of nail clippings for diagnosing onychomycosis Arch Dermatol 127 1991 1517 1519
49. T.A. Syed O.A. Ahmadpour S.A. Ahmad Management of toenail onychomycosis with 2% butenafine and 20% urea cream: A placebo-controlled study J Dermatol 25 1998 648 652
50. A. Tosti R. Baran R. Morelli Progressive fading of a longitudinal melanonychia due to a nail matrix nevus in a child Arch Dermatol 130 1994 1076 1077
51. A. Tosti B.M. Piraccini N. Cameli Calcipotriol ointment in nail psoriasis: A controlled double-blind comparison with betamethasone diproprionate and salicylic acid Br J Dermatol 139 1998 655 659
52. P.J. Velthius M. Nijenhuis Treatment of onychomycosis with terbinafine in patients with Down's syndrome Br J Dermatol 133 1995 144 145
53. G.D. Weinstein G.G. Krueger N.J. Lowe Tazarotene gel, a new retinoid, for topical therapy of psoriasis: Vehicle-controlled study of safety, efficacy, and duration of therapeutic effect J Am Acad Dermatol 37 1997 85 92
54. D.C. Wilson R.K. Scher What's new in hair and nail disorders Skin & Aging. 6 1998 21 27
55. Y. Yamamoto I. Katayama K. Nishioka Topical anthralin therapy for refractory nail psoriasis J Dermatol 25 1998 231 233
56. N. Zaias Onychomycosis Dermatol Clin 3 1985 445